3983.HK HKSE
China BlueChemical Ltd.
1W: -2.6%
1M: -5.1%
3M: -9.8%
YTD: -32.5%
1Y: -15.9%
3Y: +14.9%
5Y: -3.6%
HK$1.84 ($0.24)
-0.04 (-2.12%)
Weekly Expected Move ±2.6%
HK$2
HK$2
HK$2
HK$2
HK$2
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$1.5B
-1.4% ▼
5Y CAGR: +5.9%
Capital Expenditures
$605M
+18.7% ▲
5Y CAGR: +11.0%
Free Cash Flow
$918M
+14.7% ▲
5Y CAGR: +3.2%
Dividends Paid
$954M
-16.3% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
$83M
+20.7% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $745M | $1.5B | $1.6B | $2.4B | $1.5B |
| Depreciation & Amort. | $647M | $553M | $560M | $628M | $666M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$77M | $149M | $24M | -$66M | $162M |
| Other Non-Cash Items | -$52M | $739M | -$84M | -$1.4B | -$772M |
| Operating Cash Flow | $1.3B | $2.9B | $2.1B | $1.5B | $1.5B |
| — Investing Activities — | |||||
| Capital Expenditures | -$373M | -$1.1B | -$1.3B | -$618M | -$601M |
| Acquisitions (Net) | -$555M | $3.1B | $1.4B | $0 | $0 |
| Investment Purchases | -$5.7B | -$8.8B | -$13.3B | -$6.5B | -$8.0B |
| Investment Sales | $6.3B | $5.7B | $11.9B | $6.1B | $7.8B |
| Other Investing | $1.5B | -$2.6B | -$1.0B | $415M | $390M |
| Investing Cash Flow | $1.1B | -$3.7B | -$2.4B | -$691M | -$379M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$66M | -$933M | $1.0B | $24M | $60M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$350M | -$369M | -$715M | -$821M | -$954M |
| Other Financing | $328K | -$65M | -$264M | $12M | -$167M |
| Financing Cash Flow | -$416M | -$1.4B | $56M | -$784M | -$1.1B |
| Net Change in Cash | $1.9B | -$2.1B | -$146M | $68M | $83M |
| Cash End of Period | $2.8B | $674M | $529M | $597M | $680M |
| Free Cash Flow | $890M | $1.9B | $807M | $800M | $918M |